🇺🇸 FDA
Pipeline program

Class I or III Antiarrhythmic Medications

AFI-30

Phase 3 small_molecule completed

Quick answer

Class I or III Antiarrhythmic Medications for Atrial Fibrillation is a Phase 3 program (small_molecule) at RHYTHM PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
RHYTHM PHARMACEUTICALS, INC.
Indication
Atrial Fibrillation
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials